Treasure Global Inc’s $4.0M Public Offering – Stock Declines 46%
The stock of Treasure Global Inc, a provider of innovative technology solutions, experienced a substantial downturn after the company disclosed the details of its underwritten...
BioVie Stock Falls 62% After Phase 3 Trial Setback for NE3107
BioVie Inc, a clinical-stage company, witnessed a significant decline in its stock value as the company released topline efficacy data from its Phase 3 trial...
Stocks Rally on Opening Bell as Fed Teases Potential Rate Cuts
Stocks opened on a positive note on Wednesday following a robust reading of Gross Domestic Product (GDP), revealing that the US economy experienced faster growth...
Stocks Show Modest Gains Amidst Cautious Investor Sentiment
US stocks closed in modest gains on Tuesday, capping off a day of subdued trading as investors treaded cautiously amid growing signs that the robust...
Oil Prices Surge 2% on OPEC+ Speculation, Storm-Related Disruption, and Weaker Dollar
Tuesday saw oil prices surge 2%, propelled by a convergence of factors such as the anticipation of OPEC+ supply cut extensions or deepening, a storm-induced...
Fusion Fuel Green Secures $20 Million Financing Deal with Macquarie Group, Stock Surges
In a strategic move to bolster its position in the green hydrogen sector, Fusion Fuel Green PLC, an emerging leader, announced yesterday that it has...
HNR Acquisition Unveils Stellar Acquisition Reports, Stock Surges
In a business update that sent shockwaves through the market, HNR Acquisition Corp (HNRA), an independent oil and natural gas company, revealed significant developments and...
IceCure Medical Stock Surges After Breakthrough Study Results Reveals Unprecedented Success in Tumor Treatment
The stock of IceCure Medical Ltd experienced a significant uptick on Tuesday following the announcement of groundbreaking findings in an independent study. This study, titled...
Stocks Dip as GRI Bio Gains FDA Nod for Promising IPF Drug
GRI Bio Inc, a leading biotechnology company specializing in Natural Killer T (“NKT”) cell modulators for inflammatory, fibrotic, and autoimmune diseases, announced yesterday that the...
CohBar Inc Faces Nasdaq Delisting Amidst Regulatory Concerns, Stock Dips
In a notable turn of events on November 20, 2023, CohBar Inc, a clinical stage biotechnology company, was notified by The Nasdaq Stock Market LLC’s...
